GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.

An Illinois jury sided with Boehringer Ingelheim in a Zantac cancer lawsuit. Learn about the legal angles, previous trial ...

For the study, published in Open Forum Infectious Diseases, a team led by a University of Virginia (UVA) researcher and PRIME ...

GSK PLC closed 20.35% short of its 52-week high of £18.24, which the company achieved on May 16th.

Belgium plans to reinforce its global competitiveness in clinical research as the new government sets an ambitious course for pharma progress.

GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...

Veterinarians on Prince Edward Island who have been monitoring the spread of avian influenza for years are encouraged by the ...

Britain's blue-chip FTSE 100 kicked off the week higher on Monday, boosted by heavyweight healthcare and defence stocks, on ...

The FTSE 100 index saw an uptick, driven by healthcare and defence stocks, bouncing back from a four-day downturn. BAE ...

GSK (GSK) plc announces the commencement of its share buyback program, as announced in its 2024 full year results announcement published on 5 ...

GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...

Two former FTSE 100 stocks were in the spotlight today after Just Eat Takeaway.com backed a £3.4 billion takeover and B&M ...